Circle Soared Almost This Year: One Catalyst to Watch
Circle has delivered a dramatic swing in 2024. This article breaks down the main reason it could keep climbing, the r...
Which index fund performed best this year? Review top performers, volatility, and potential shifts to inform your next move.
26,831 articlesCircle has delivered a dramatic swing in 2024. This article breaks down the main reason it could keep climbing, the r...
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
New data on the gender wage gap show women still earn far less than men, marking a second straight year of ground los...
Price dips in tech stocks can hide real strength. This article explains why a stock with improving fundamentals might...
Could Palantir move higher over the next year? This guide breaks down three realistic scenarios, key catalysts, and p...
A retiree’s hesitation to touch a Roth IRA for fear of higher Medicare costs and Social Security taxes is untrue: qua...
Everus ECG's 2026 earnings story hinges on growing recurring revenue and cash flow turnarounds. This analysis breaks ...
A practical, investor-focused breakdown of fermi (frmi) 2025 earnings. We unpack Q4 results, margins, and the growth ...
LuxExperience reports solid Q3 2026 results with growing revenue and improving margins. This article breaks down the ...
Investors eye Xcel Brands (XELB) 2026 as it reports Q1 results. This guide explains what to look for in the transcrip...
A new LodeStar study shows national purchase loan closing costs declined 2.9% in 2025, driven by lower home prices an...
P&G leads with broad-based growth and new investments across beauty and global markets, while Colgate-Palmolive leans...